Mylan AIDS Drug Tentatively Cleared by FDA

Mylan Inc., the Pittsburgh drugmaker, said its 71.5 percent-owned Indian subsidiary, Matrix Laboratories, received tentative clearance from the U.S. Food and Drug Administration to market tenofovir disoproxil fumarate tablets in a 300-milligram dose.
MarketWatch